JP2013508411A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508411A5
JP2013508411A5 JP2012535426A JP2012535426A JP2013508411A5 JP 2013508411 A5 JP2013508411 A5 JP 2013508411A5 JP 2012535426 A JP2012535426 A JP 2012535426A JP 2012535426 A JP2012535426 A JP 2012535426A JP 2013508411 A5 JP2013508411 A5 JP 2013508411A5
Authority
JP
Japan
Prior art keywords
diet
patient
food
therapeutic
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012535426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/053821 external-priority patent/WO2011050302A2/en
Publication of JP2013508411A publication Critical patent/JP2013508411A/ja
Publication of JP2013508411A5 publication Critical patent/JP2013508411A5/ja
Pending legal-status Critical Current

Links

JP2012535426A 2009-10-22 2010-10-22 癌治療の効果を高め、その副作用を軽減する方法および栄養製剤 Pending JP2013508411A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25415409P 2009-10-22 2009-10-22
US61/254,154 2009-10-22
PCT/US2010/053821 WO2011050302A2 (en) 2009-10-22 2010-10-22 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment

Publications (2)

Publication Number Publication Date
JP2013508411A JP2013508411A (ja) 2013-03-07
JP2013508411A5 true JP2013508411A5 (https=) 2013-11-21

Family

ID=43900993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535426A Pending JP2013508411A (ja) 2009-10-22 2010-10-22 癌治療の効果を高め、その副作用を軽減する方法および栄養製剤

Country Status (13)

Country Link
US (2) US20110118528A1 (https=)
EP (1) EP2490684B1 (https=)
JP (1) JP2013508411A (https=)
CN (1) CN102753162A (https=)
AU (2) AU2010310515B2 (https=)
BR (1) BR112012009423A2 (https=)
CA (1) CA2779282C (https=)
DK (1) DK2490684T3 (https=)
ES (1) ES2659353T3 (https=)
PL (1) PL2490684T3 (https=)
PT (1) PT2490684T (https=)
RU (1) RU2549954C2 (https=)
WO (1) WO2011050302A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2888811C (en) * 2012-10-22 2023-10-24 University Of Southern California A diet package, and uses thereof
CN109187991B (zh) 2013-02-12 2021-12-24 南加利福尼亚大学 为受试者提供合理蛋白质膳食的方法
WO2015002972A1 (en) * 2013-07-01 2015-01-08 University Of Southern California Fasting condition as dietary treatment of diabetes
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
JP6859567B2 (ja) * 2014-03-06 2021-04-14 ユニヴァーシティ オブ サザン カリフォルニアUniversity of Southern California 従来の化学療法剤の効力および実行可能性を増強し、かつ正常な細胞および組織におけるキナーゼの副作用を逆転させるための、キナーゼ阻害剤と併用した短期間絶食レジメンの使用
US10117872B2 (en) * 2014-03-28 2018-11-06 Università Degli Studi Di Genova Tyrosine kinase inhibitors for use in a method of treating cancer in association with a reduced caloric intake
CA2944479C (en) * 2014-04-02 2023-02-21 University Of Southern California Dietary formulation and method for treating autoimmune and inflammatory diseases
AU2016248443B2 (en) * 2015-04-16 2021-03-18 University Of Southern California Fasting mimicking diet (FMD) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone
RU2724525C2 (ru) 2015-05-06 2020-06-23 Юниверсити Оф Саутерн Калифорния Способ лечения повышенных уровней инсулина или глюкозы с использованием гипокалорийного или бескалорийного рациона или рациона, имитирующего воздержание от пищи
EP3352793A1 (en) * 2015-09-21 2018-08-01 IFOM Fondazione Istituto Firc di Oncologia Molecolare New therapeutic strategies against blood cancer
EP3402345A4 (en) * 2016-01-12 2019-09-11 University of Southern California USE OF LONG-TERM FAST FOR IMMEDIATE DIETARY TREATMENT OF MULTIPLE MYELOMA AND OTHER CANCER TYPES
JP2019505592A (ja) 2016-02-15 2019-02-28 ユニバーシティ オブ サザン カリフォルニア 糖尿病及び他の疾患を治療するための胚様再生を刺激するための薬剤の組み合わせ及び方法
CN109069462A (zh) 2016-02-23 2018-12-21 癌症研究科技有限公司 缺乏至少两种非必需氨基酸的膳食产品
US11540550B2 (en) 2016-05-11 2023-01-03 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases
IT201700008499A1 (it) * 2017-01-26 2018-07-26 Univ Degli Studi Genova Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN107951892A (zh) * 2018-01-19 2018-04-24 丽水学院 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用
EP3765046A4 (en) 2018-03-15 2022-04-27 University Of Southern California BUT NOT EXCLUSIVELY WATER-BASED DIET (FMD) FACILITATES THE REVERSAL OF INFLAMMATION AND INFLAMMATORY BOWEL DISEASE
US20210267250A1 (en) * 2018-07-18 2021-09-02 Andreas Michalsen Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer
MX2021005465A (es) 2018-11-09 2021-12-15 L Nutra Barra nutricional para simular el ayuno intermitente.
WO2020223522A1 (en) 2019-04-30 2020-11-05 University Of Southern California Fasting-mimicking diet (fmd) as an intervention for alzheimer's disease (ad)
JP6747702B1 (ja) * 2019-05-10 2020-08-26 株式会社医療情報技術研究所 栄養処方管理システム
WO2020232227A1 (en) 2019-05-14 2020-11-19 Tyme, Inc. Compositions and methods for treating cancer
IT201900009954A1 (it) * 2019-06-24 2020-12-24 Fondazione Irccs Istituto Naz Dei Tumori Preparazione alimentare a basso contenuto calorico per l’alimentazione di pazienti affetti da neoplasie
JP7376718B2 (ja) * 2019-12-13 2023-11-08 株式会社ベリタスバイオセラピューティクス 癌の予防または治療用薬学組成物
IT202000007153A1 (it) 2020-04-03 2021-10-03 Ifom Fondazione St Firc Di Oncologia Molecolare Apporto calorico ridotto e immunoterapia per il trattamento del cancro
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections
JP2023530235A (ja) 2020-06-03 2023-07-14 フェス・セラピューティクス,インコーポレーテッド 個別化された処置方法のための製剤
WO2021247923A1 (en) 2020-06-04 2021-12-09 Faeth Therapeutics, Inc. Personalized methods of treating cancer
TW202227113A (zh) 2020-12-01 2022-07-16 南加州州立大學 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活
CA3205396A1 (en) * 2020-12-17 2022-06-23 Licia Rivoltini Diet preparation for the nutrition of cancer patients with a restricted calorie intake
EP4066823B1 (en) 2021-03-30 2025-04-30 IFOM - Istituto Fondazione di Oncologia Molecolare ETS Reduced caloric intake and anticancer agents for the treatment of cancer
CN115590963A (zh) * 2022-07-13 2023-01-13 复旦大学(Cn) 酮体、酮体诱导剂和生酮组合物中的至少一种在治疗和/或预防血小板减少症药物中的应用
EP4599826A1 (en) 2024-02-06 2025-08-13 IFOM - Istituto Fondazione di Oncologia Molecolare ETS Leucine for use in the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074731C1 (ru) * 1994-12-29 1997-03-10 Игорь Александрович Бойко Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных
CA2283642C (en) * 1997-03-17 2012-05-15 Btg International Limited Therapeutic compositions
AU5319499A (en) * 1999-07-22 2001-02-13 Ivan L. Cameron Fatty acids to minimize cancer therapy side effects
JP4625156B2 (ja) * 2000-04-10 2011-02-02 イーエヌ大塚製薬株式会社 癌化学療法に伴う副作用軽減剤
WO2005117542A2 (en) * 2004-05-10 2005-12-15 Novacea, Inc. Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
WO2006043966A2 (en) * 2004-10-15 2006-04-27 University Of Tennessee Research Foundation Methods for inducing apoptosis in adipocytes
US20070116802A1 (en) * 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
RU2354369C2 (ru) * 2007-03-16 2009-05-10 Михаил Владимирович Кутушов Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов
EP2156188B1 (en) * 2007-03-28 2021-05-05 University of Southern California Induction of differential stress resistance and uses thereof
US20110077198A1 (en) * 2007-11-26 2011-03-31 Michael John Tisdale Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition

Similar Documents

Publication Publication Date Title
JP2013508411A5 (https=)
Miyata et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer
Frame‐Peterson et al. Nutrient deficiencies are common prior to bariatric surgery
RU2012118588A (ru) Способы и диетологические составы для повышения эффективности и снижения побочных эффектов лечения рака
MacDonald et al. Understanding and managing cancer cachexia
Richter et al. Parenteral nutrition support for patients with pancreatic cancer–improvement of the nutritional status and the therapeutic outcome
Garla et al. Nutritional therapy in gastrointestinal cancers
Montégut et al. Science-driven nutritional interventions for the prevention and treatment of cancer
Kita et al. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer
Greenlee Natural products for cancer prevention
US10675262B2 (en) Development of dietary therapy in cancer
Singla et al. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: A comprehensive review of preclinical and clinical studies
Gobato et al. Micronutrient and physiologic parameters before and 6 months after RYGB
RU2734774C2 (ru) Рацион, имитирующий воздержание от пищи (fmd), и лекарственные средства, снижающие уровень глюкозы, защищают нормальные клетки и создают условия сенсибилизации при раке в ответ на стандартные условия и условия с высоким содержанием глюкозы, индуцированные рапамицином и дексаметазоном
JP6859567B2 (ja) 従来の化学療法剤の効力および実行可能性を増強し、かつ正常な細胞および組織におけるキナーゼの副作用を逆転させるための、キナーゼ阻害剤と併用した短期間絶食レジメンの使用
US20210145915A1 (en) Formulations for weight loss and methods of use
Ben-Arye et al. Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication
Panda et al. Nutritional aspects of healthy aging
Meegaswatte et al. Functional foods and nutraceuticals for the management of cardiovascular disease risk in postmenopausal women
Bibby et al. Nutritional considerations for the management of the older person with hepato-pancreatico-biliary malignancy
Munguti et al. A rare cause of cardiomyopathy: a case of selenium deficiency causing severe cardiomyopathy that improved on supplementation
Arends et al. Non-surgical oncology–guidelines on parenteral nutrition, chapter 19
Bıçaklı Individualized nutritional management for cancer patients: a key component of treatment
Moyad Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods
Ellis Nutrition and healthy aging